Table 3 Markers and their value in prediction in breast cancer
Established and in routine clinical usePotential for clinical use; need refinement of scoring systems or antibodiesResearch interest, less likely to be used clinically
Oestrogen receptorEpidermal growth factor receptorP53
Progesterone receptorKi-67 (MIB-1)Cyclin E, cyclin D1, p21, p27
HER2Topoisomerase II alphaBcl2, bax, bcl-x, survivin